By Dr. Ramesh Chandra, MD (Endocrinology) | Apr 11, 2026
Dengue fever is an acute mosquito-borne viral illness caused by four serologically distinct dengue virus serotypes (DEN-1, DEN-2, DEN-3, and DEN-4) belonging to the genus Flavivirus. Transmitted across tropical and subtropical regions by female Aedes aegypti and Aedes albopictus mosquitoes, dengue represents one of the fastest-spreading vector-borne viral infections worldwide. In India, annual epidemic surges coincide with monsoon and post-monsoon seasons (July to November), driven by stagnant water accumulation and favorable humidity for vector breeding.
Infection with one serotype confers lifelong immunity against that specific serotype, but subsequent secondary infection with a different serotype significantly increases the risk of severe dengue, including Dengue Hemorrhagic Fever (DHF) and Dengue Shock Syndrome (DSS), due to antibody-dependent enhancement (ADE).
Dengue viral pathogenesis proceeds through three distinct clinical phases following an incubation period of 4 to 10 days:
Early symptom identification is essential for preventing severe hemorrhagic complications. Common manifestations include:
Standard laboratory confirmation combines viral antigen testing, antibody serology, and serial complete blood counts:
There is currently no specific direct antiviral medication for dengue infection. Clinical care relies on meticulous fluid replacement and symptom management:
Preventing dengue transmission depends on interrupting the Aedes aegypti breeding cycle:
Q: Can dengue fever be treated at home?A: Mild dengue without warning signs can be managed at home with abundant ORS fluids, paracetamol, and bed rest under daily platelet monitoring.
Q: When is platelet transfusion required in dengue?A: Platelet transfusion is generally reserved for patients with severe active bleeding or platelet counts dropping below 10,000/?L without bleeding.
Please enter your 4-digit Secure PIN to authorize this action.